# PACS Group Inc. (PACS) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Providers & Services. Price $42.50, market value $6.7 billion.

## Valuation
- **P/E (trailing): 24.9×** (5-yr avg 33.0×, 3-yr avg 33.0×). PACS Group Inc. trades at 24.9× trailing earnings, well below its own five-year average of 33.0×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 15.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.2×**. Each dollar of revenue is priced at 1.2×.
- **Price / book: 6.1×**. The shares trade at 6.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Earnings yield: 4.0%**. The inverse of the P/E: 4.0% of the price is earned each year.

## Profitability
- **Operating margin: 7.4%**. 7.4% of revenue is left after running the business.
- **Net margin: 3.6%**. 3.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 20.2%**. 20.2% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 32.4%**. Return on all capital, debt included, is 32.4%: comfortably above what that capital costs.
- **Return on assets: 4.8%**. Each dollar of assets produces 4.8% of profit.

## Growth
- **Revenue growth (1 yr): 29.4%** (3-yr 30.1%/yr). Revenue grew 29.4% over the last year.
- **EPS growth (1 yr): 221.1%** (3-yr 1.4%/yr). Earnings per share rose 221.1%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.26**. Debt is 0.26 times equity: a conservative balance sheet.
- **Altman Z-score: 2.24**. A Z-score of 2.24 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. PACS Group Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (6 analysts). 6 analysts cover PACS Group Inc.; the consensus is strong_buy, with an average price target of $59.00 (+39% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 278.5%** (YTD 10.7%, 3-mo 14.8%). The shares are up 278.5% over twelve months including dividends.
- **From 52-week high: -14.1%** (466.7% above the low). Trading 14% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 41**. An RSI of 41 is neutral.
- **Beta (1 yr): 0.43** (volatility 102%). Beta of 0.43 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PACS · Page: https://foliofundamentals.com/stocks/pacs

Not investment advice.